Donepezil for mild cognitive impairment - Wikidata - wikimedia - TriplyDB

Donepezil for mild cognitive impairment

Donepezil for mild cognitive impairment

http://www.wikidata.org/entity/Q24245534

about

Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials Huperzine A for mild cognitive impairment Huperzine A for mild cognitive impairment Testosterone supplementation for mild cognitive impairment and dementia Recent advances in the application of metabolomics to Alzheimer's Disease Diagnostic tools for alzheimer's disease dementia and other dementias: an overview of diagnostic test accuracy (DTA) systematic reviews Treatment for mild cognitive impairment: systematic review.Changes in cerebral glucose metabolism after 3 weeks of noninvasive electrical stimulation of mild cognitive impairment patients Caregivers in China: knowledge of mild cognitive impairment.Alzheimer's disease & metals: therapeutic opportunities.The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation Magnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study.Patient self-report for evaluating mild cognitive impairment and prodromal Alzheimer's disease.Non-pharmacological interventions for adults with mild cognitive impairment and early stage dementia: An updated scoping review Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study.Dementia syndromes: evaluation and treatment Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis.Magnetic resonance imaging for monitoring therapeutic response in a transgenic mouse model of Alzheimer's disease using voxel-based analysis of amyloid plaques.Cognitive impairment.Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease.Developing a Non-Pharmacological Intervention for Individuals With Mild Cognitive Impairment.Mild Cognitive Impairment, Neurodegeneration, and Personalized Lifestyle Medicine The Black Book of Psychotropic Dosing and Monitoring.Using Cerebrospinal Fluid Biomarker Testing to Target Treatment to Patients with Mild Cognitive Impairment: A Cost-Effectiveness Analysis.Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study.Efficacy and Safety of Auricular Acupuncture for Cognitive Impairment and Dementia: A Systematic Review.Identification of the optimal cognitive drugs among Alzheimer’s disease: a Bayesian meta-analytic review Association between cognitive impairment and poor antihypertensive medication adherence in elderly hypertensive patients without dementia

P2860

Q21092367-6DE68150-4EB5-48D1-928D-A8BFE9CDFAB3 Q24202101-4DAB6E1B-34E2-47FB-9444-5328A4182E74 Q24234330-D6D9C7C6-8054-4207-B67D-0E1C74F77188 Q24240719-66CF0E02-2BB5-46F0-B97A-DE1CEBFEE118 Q26828606-3B05C969-636C-4D29-8A6E-018A01AEC40A Q34306619-303C12A9-5FE8-4E2C-B546-D9134808AC45 Q34374748-6607F854-15E0-490E-8620-0C6212D9B445 Q34546285-F16713EF-C89A-4968-A303-52B36853A9C4 Q34551959-925DCF74-1C4F-4EDB-808A-8142D11576D5 Q34919551-421190FF-4FAE-485A-83A2-E53F149B5B49 Q35042798-8450C560-FCFC-4C79-946F-6C8DD46FA572 Q35319467-7F8289A3-B02A-48EC-8423-809698C79FDF Q35840627-6332A3AA-C6B9-4083-8935-E34F595D3EFB Q36144815-9804AFB2-8F02-4B02-932E-08DF66885B21 Q36288900-C1E5C7AB-8E76-4944-8581-B541C5662075 Q36787352-53CFD8FA-C456-45C3-8FB2-01FA84582A20 Q37304526-BF0B6AD1-7C67-445A-BE71-E5F53DDA9CF9 Q37585625-AAFC072C-EA24-413B-B221-415D19F9A7B7 Q41143369-C8B04B41-5AA9-4E50-AD5C-B138AE756F12 Q41718243-18A59A71-F852-4CF2-86E6-1A41D6732527 Q42380897-ED6DF3D0-8862-435C-8531-1307A7E2DBE2 Q42737354-4DA03AAC-73A4-4A21-9226-06F4510082F6 Q47642128-553EE964-23F7-4763-96F3-DEE60CF56B17 Q53416948-2F2BACE7-4868-47E7-B988-2E0FEE21C17F Q53689882-B2D26B0F-08F4-4C14-A183-3D87A629689D Q55438702-DB99C64A-5953-4200-9AF7-C0B7D211A509 Q58698874-A856625E-04C3-4FFD-9704-045843EF77B9 Q58802373-E4208878-7431-4AA5-B707-73D8146EA823

P2860

Donepezil for mild cognitive impairment

http://www.wikidata.org/entity/Q24245534

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Donepezil for mild cognitive impairment

@ast

Donepezil for mild cognitive impairment

@en

Donepezil for mild cognitive impairment

@en-gb

Donepezil for mild cognitive impairment

@nl

type

label

Donepezil for mild cognitive impairment

@ast

Donepezil for mild cognitive impairment

@en

Donepezil for mild cognitive impairment

@en-gb

Donepezil for mild cognitive impairment

@nl

prefLabel

Donepezil for mild cognitive impairment

@ast

Donepezil for mild cognitive impairment

@en

Donepezil for mild cognitive impairment

@en-gb

Donepezil for mild cognitive impairment

@nl

P1433

Q24245534-3C7276AF-5353-4B3C-929E-21FA4E94CEC8

P1476

Q24245534-04276456-CC8D-4514-B225-C27B56CEF6E8

P2093

Q24245534-0691AED7-0A58-46C4-8087-340E56F6FF32

P2860

Q24245534-0F09FEA4-BA21-4E71-9E63-6E2A8EBBB98F

Q24245534-25BD3B1E-1CD6-458B-8941-8F50553D8797

Q24245534-345A53A2-E5AA-4816-ACA3-5C4BF1BF2D63

Q24245534-497F6906-2620-47E5-B8C5-03A8BB370075

Q24245534-785BD602-F547-48BD-B128-DE35DB472393

Q24245534-82F41620-71D9-41BF-8D75-957CE4B2FF5B

Q24245534-8F236451-6DEE-4947-905A-9CCBE2D1F799

Q24245534-A4A927DF-682E-42CE-9462-3E82AA252BEA

Q24245534-B2702FF0-83DA-40AA-A971-657D852C780E

Q24245534-D72B25B9-4A3E-4C48-87C2-8670194897F2

P304

Q24245534-EEE06751-F69B-48FF-8A46-F24D9148B577

P31

Q24245534-B0042142-51CA-4AFB-BF47-7C4187C7F537

P356

Q24245534-6CFD3B1E-75FB-4429-8E89-1F842C32F3D8

P407

Q24245534-62470AEC-1149-488B-83DD-7249DFB4C17C

P433

Q24245534-6EDF4F1D-265B-424D-B762-0D8E343B6349

P50

Q24245534-647D9136-EDE8-407B-A205-E7A1F9EF9B46

P577

Q24245534-D81F60B7-E4CF-44B3-A393-A18D286AE1C2

P698

Q24245534-57C51746-3B67-42C2-887B-8342C4CF149C

P356

14651858.CD006104

P1433

Cochrane Database of Systematic Reviews

P1476

Donepezil for mild cognitive impairment

@en

P2093

Leon Flicker

http://www.w3.org/2001/XMLSchema#string

P2860

Donepezil for dementia due to Alzheimer's disease

“Mini-mental state”

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Donepezil effects on cerebral blood flow in older adults with mild cognitive deficits.

Current concepts in mild cognitive impairment.

Vitamin E and donepezil for the treatment of mild cognitive impairment.

Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.

Alzheimer's disease: the benefits of early treatment.

Neuropsychological prediction of decline to dementia in nondemented elderly.

P304

CD006104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/14651858.CD006104

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P50

Jacqueline Birks

P577

2006-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16856114

http://www.w3.org/2001/XMLSchema#string